Armata Pharmaceuticals, Inc. (ARMP)
5.77
+0.25
(+4.53%)
USD |
NYAM |
Sep 04, 13:15
Armata Pharmaceuticals Max Drawdown (5Y) : 98.51% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 98.51% |
| July 31, 2026 | 98.64% |
| June 30, 2026 | 98.67% |
| May 31, 2026 | 98.67% |
| April 30, 2026 | 99.11% |
| March 31, 2026 | 99.17% |
| February 28, 2026 | 99.39% |
| January 31, 2026 | 99.39% |
| December 31, 2025 | 99.59% |
| November 30, 2025 | 99.64% |
| October 31, 2025 | 99.64% |
| September 30, 2025 | 99.73% |
| August 31, 2025 | 99.74% |
| July 31, 2025 | 99.74% |
| June 30, 2025 | 99.74% |
| May 31, 2025 | 99.74% |
| April 30, 2025 | 99.74% |
| March 31, 2025 | 99.74% |
| February 28, 2025 | 99.78% |
| January 31, 2025 | 99.78% |
| December 31, 2024 | 99.78% |
| November 30, 2024 | 99.78% |
| October 31, 2024 | 99.78% |
| September 30, 2024 | 99.78% |
| August 31, 2024 | 99.78% |
| Date | Value |
|---|---|
| July 31, 2024 | 99.78% |
| June 30, 2024 | 99.78% |
| May 31, 2024 | 99.78% |
| April 30, 2024 | 99.78% |
| March 31, 2024 | 99.78% |
| February 29, 2024 | 99.78% |
| January 31, 2024 | 99.78% |
| December 31, 2023 | 99.78% |
| November 30, 2023 | 99.78% |
| October 31, 2023 | 99.78% |
| September 30, 2023 | 99.78% |
| August 31, 2023 | 99.78% |
| July 31, 2023 | 99.78% |
| June 30, 2023 | 99.78% |
| May 31, 2023 | 99.78% |
| April 30, 2023 | 99.78% |
| March 31, 2023 | 99.78% |
| February 28, 2023 | 99.78% |
| January 31, 2023 | 99.78% |
| December 31, 2022 | 99.78% |
| November 30, 2022 | 99.78% |
| October 31, 2022 | 99.78% |
| September 30, 2022 | 99.78% |
| August 31, 2022 | 99.78% |
| July 31, 2022 | 99.78% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Agenus, Inc. | 98.84% |
| Amgen, Inc. | 24.86% |
| Anika Therapeutics, Inc. | 83.15% |
| BioCryst Pharmaceuticals, Inc. | 79.10% |
| Imunon, Inc. | 99.49% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -7.037 |
| Beta (5Y) | 1.339 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 136.7% |
| Historical Sharpe Ratio (5Y) | 0.0373 |
| Historical Sortino (5Y) | 0.1208 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.86% |